Do we know bad science when we see it?

被引：8

作者：

Jones, David R. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Thorac Surg Serv, New York, NY 10065 USA

来源：

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2015年 / 150卷 / 03期

关键词：

D O I：

10.1016/j.jtcvs.2015.07.032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：472 / 473

页数：2

相关论文

共 3 条

[1] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].

Chang, Joe Y. ;

Senan, Suresh ;

Paul, Marinus A. ;

Mehran, Reza J. ;

Louie, Alexander V. ;

Balter, Peter ;

Groen, Harry J. M. ;

McRae, Stephen E. ;

Widder, Joachim ;

Feng, Lei ;

van den Borne, Ben E. E. M. ;

Munsell, Mark F. ;

Hurkmans, Coen ;

Berry, Donald A. ;

van Werkhoven, Erik ;

Kresl, John J. ;

Dingemans, Anne-Marie ;

Dawood, Omar ;

Haasbeek, Cornelis J. A. ;

Carpenter, Larry S. ;

De Jaeger, Katrien ;

Komaki, Ritsuko ;

Slotman, Ben J. ;

Smit, Egbert F. ;

Roth, Jack A. .

LANCET ONCOLOGY, 2015, 16 (06) :630-637

[2]

Galilei G., 1957, DISCOVERIES OPINIONS, P237

[3] Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence? [J].

Meyers, Bryan F. ;

Puri, Varun ;

Broderick, Stephen R. ;

Samson, Pamela ;

Keogan, Kathleen ;

Crabtree, Traves D. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (03) :468-471